425 related articles for article (PubMed ID: 28850007)
21. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
Adamsen BL; Kravik KL; De Angelis PM
Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
[TBL] [Abstract][Full Text] [Related]
22. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
23. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
Yun S; Han YS; Lee JH; Kim S; Lee SH
Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
[TBL] [Abstract][Full Text] [Related]
24. Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells.
Ng PL; Rajab NF; Then SM; Mohd Yusof YA; Wan Ngah WZ; Pin KY; Looi ML
J Zhejiang Univ Sci B; 2014 Aug; 15(8):692-700. PubMed ID: 25091987
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.
Gustafsson SB; Lindgren T; Jonsson M; Jacobsson SO
Cancer Chemother Pharmacol; 2009 Mar; 63(4):691-701. PubMed ID: 18629502
[TBL] [Abstract][Full Text] [Related]
26. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
28. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
[TBL] [Abstract][Full Text] [Related]
29. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955
[TBL] [Abstract][Full Text] [Related]
30. Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
Kotlarz A; Przybyszewska M; Swoboda P; Miłoszewska J; Grygorowicz MA; Kutner A; Markowicz S
Tumour Biol; 2016 Apr; 37(4):4699-709. PubMed ID: 26511971
[TBL] [Abstract][Full Text] [Related]
31. Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.
Bijnsdorp IV; Peters GJ; Temmink OH; Fukushima M; Kruyt FA
Int J Cancer; 2010 May; 126(10):2457-68. PubMed ID: 19816940
[TBL] [Abstract][Full Text] [Related]
32. l-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis.
Iovine B; Guardia F; Irace C; Bevilacqua MA
Biochimie; 2016 Aug; 127():196-204. PubMed ID: 27234614
[TBL] [Abstract][Full Text] [Related]
33. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells.
Fujita H; Kato J; Horii J; Harada K; Hiraoka S; Shiraha H; Sakaguchi K; Shiratori Y
Oncol Rep; 2007 Nov; 18(5):1129-37. PubMed ID: 17914563
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration.
Choi JH; Yoon JS; Won YW; Park BB; Lee YY
APMIS; 2012 Jul; 120(7):597-604. PubMed ID: 22716215
[TBL] [Abstract][Full Text] [Related]
37. Fucoxanthin Holds Potential to Become a Drug Adjuvant in Breast Cancer Treatment: Evidence from 2D and 3D Cell Cultures.
Malhão F; Macedo AC; Costa C; Rocha E; Ramos AA
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299562
[TBL] [Abstract][Full Text] [Related]
38. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
39. The anticancer effects and mechanisms of fucoxanthin combined with other drugs.
Wang Z; Li H; Dong M; Zhu P; Cai Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):293-301. PubMed ID: 30627824
[TBL] [Abstract][Full Text] [Related]
40. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
